CPT III codes for psychedelic-assisted therapies are now in effect in the U.S. These codes provide HCPs with a means to seek coverage and reimbursement for delivering psychedelic-assisted therapy to patients, if such therapies receive approval by the FDA. https://t.co/S78RBCkUSl pic.twitter.com/dQgifwzdzF
— MAPS_PBC (@maps_pbc) January 2, 2024
For background MM have written this
